It works by mimicking GLP-1 hormone activity, which reduces appetite, slows digestion, and improves insulin release
Studies examining body composition changes during GLP-1 therapy, including the STEP trials (semaglutide) and SURMOUNT-1 (tirzepatide), have demonstrated that approximately 2540% of total weight lost may come from lean body mass, including skeletal muscle, rather than exclusively from fat mass
Newsletter Signup
Whilst this affects everybody to an extent, there is a strong class character to this question
[PubMed] Storage and Handling (Laboratory Use Only) Store lyophilized material at -20C or below, protected from light
Although some guidelines like KDIGO define abnormal albuminuria as 3 mg/mmol for people both with and without diabetes [17], our working group continues to prefer a cutpoint of 2.0 mg/mmol, as we have since 1998 [29]